|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
85 Bolton St,Cambridge,Massachusetts,US
|
|
Founded in 2020, Cargene Biopharma is a preclinical-stage biopharmaceutical company developing innovative oligonucleotide therapeutics for liver fibrosis and ophthalmic disorders, with operations in Singapore, USA and China.
Using proprietary platforms backed by novel biology and chemistry insights, Cargene aims to improve quality of life for millions of patients worldwide through creating highly specific, stable and potent nucleic acid-based medicines for the treatment of a broad range of diseases.
In December 2021, Cargene successfully closed an over-subscribed US$19.2 million pre-Series A funding round led by BioTrack Capital, with participation from Hyfinity Investments, Legendstar Capital and other renowned investors.
|
Cargene Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Cargene Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Cargene Therapeutics customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.